[1]张华涛,陈婕,许军,等.夏橘化瘀胶囊对严重冠心病三支病变患者左室重构及心血管事件的影响*[J].陕西中医,2019,(11):1538-1540.
　ZHANG Huatao,CHEN Jie,XU Jun,et al.The effect of Xiaju Huayu capsule on ventricular remodeling and cardiovascular events in patients with severe coronary heart disease for triple branch lesion[J].,2019,(11):1538-1540.
点击复制

夏橘化瘀胶囊对严重冠心病三支病变患者左室重构及心血管事件的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年11期
页码:
1538-1540
栏目:
临床研究
出版日期:
2019-11-05

文章信息/Info

Title:
The effect of Xiaju Huayu capsule on ventricular remodeling and cardiovascular events in patients with severe coronary heart disease for triple branch lesion
文章编号:
DOI:10.3969/j.issn.10007369.2019.11.014
作者:
张华涛1; 陈婕2; 许军1; 王霞1; 李杰1; 张立平1; 陈阳1
1.山东省潍坊市中医院（潍坊 261041）；2.山东省潍坊市疾病预防控制中心（潍坊 261061）
Author(s):
ZHANG Huatao; CHEN Jie; XU Jun; et al.
Weifang Traditional Chinese Hospital in Shandong Province (Weifang 261041)
关键词:
夏橘化瘀胶囊; 严重冠心病; 三支病变; 心室重构; 左室舒张末期内径; 左室重量指数
Keywords:
Key words Xiaju Huayu capsule; Severe coronary heart disease; Triplevessel coronary artery; Ventricular remodeling; LVEDD; LVMI
分类号:
R541.4
文献标志码:
A
摘要:
摘要目的：观察夏橘化瘀胶囊对严重冠心病三支病变患者左室重构的临床疗效及安全性。方法：选取严重冠心病三支病变患者80例，按随机数字表法分为对照组和治疗组各40例，对照组采用常规治疗，治疗组在对照组基础上加夏橘化瘀胶囊。采用GE VIVID E9心血管彩超观察治疗3个月后两组患者左室舒张末期内径（LVEDD）、左室收缩末期内径（LVESD）、左室重量指数（LVMI）和室壁运动指数（WMI）的变化，治疗3个月后两组患者血脂变化情况，并随访3个月内心血管事件发生情况，记录两组不良反应发生情况。结果：治疗后两组LVEDD、LVESD、LVMI、WMI均较治疗前改善，组内对比差异有统计学意义（P＜005）；治疗组较对照组改善更明显，差异有统计学意义（P＜005）。治疗后两组总胆固醇（TCHO）、甘油三酯（TG）、低密度胆固醇（LDLC）均较治疗前改善，组内对比差异有统计学意义（P＜005）；治疗组较对照组改善更明显，差异有统计学意义（P＜005）。治疗组的心血管事件发生率明显低于对照组（P＜005）；两组不良反应发生率比较，差异无统计学意义（P＞005）。结论：夏橘化瘀胶囊可明显改善严重冠心病三支病变患者的左室重构情况，减少心血管事件的发生率。
Abstract:
AbstractObjective:To observe the effect of Xiaju Huayu capsule on ventricular remodeling and cardiovascular events in patients with triplevessel coronary artery disease.Methods:Patients with triplevessel coronary artery disease were randomly divided into the control group and the treatment group.The control group was treated with conventional drug theraty of coronary heart disease,and the treatmeat group was treated with conventional western medicine treatment plus Xiaju Huayu capsule.These therapies were lasted for 3 months.Some indices being observed by the twodimensional echocardiography were compared before and after treatment including the left ventricular end diastolic diameter (LVEDD)、the left ventricular end systolic diameter (LVESD)、the left ventricular mass index (LVMI ) and the wall motion index (LVMI ).Blood lipid levels of two groups were compared before and after treatment.The cardiovascular events were followed up for 3 months and observe the adverse reaction of two groups of patients.Results:LVEDD、LVESD、LVMI and LVMI of the two groups were better compared with before treatmeat(P＜005).LVEDD、LVESD、LVMI and LVMI of the treatment group was better than the control group,the difference was statistically significant(P＜005).TCHO、TG and LDLC of the two groups were better compared with before treatmeat(P＜005),and the treatment group was better than the control group,the difference was statistically significant(P＜005).The cardiovascular events of the treatment group was lower than the control group (P＜005).The incidence of adverse events showed no difference between the two groups (P＜005). Conclusions:Xiaju Huayu capsule can significantly improve the ventricular remodeling and cardiovascular events in patients with triplevessel coronary artery disease.

参考文献/References:

[1]刘红,张玲燕,杨玲.血府逐瘀汤治疗冠心病介入术后心绞痛临床研究[J].陕西中医,2019,40(5):594596.
[2]胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209220.
[3]张华涛,陈婕,李杰,等.夏橘化瘀胶囊联合西医常规治疗气虚血瘀型冠心病稳定型心绞痛的疗效观察[J].河北中医,2017,39(9):13481352.
[4]张华涛,陈婕,李杰,等.夏橘化瘀胶囊治疗缺血性心肌病心力衰竭疗效观察[J].河北中医,2017,39(8):11961198.
[5]Verma S,Anderson TJ.Funamentals of endothelial function for the clinical cardiologist [J].Circulation,2012,105(5):546549.
[6]史伟东,胡云平,冯燕,等.阿司匹林肠溶片联合氯吡格雷治疗冠心病不稳定型心绞痛疗效研究[J].陕西医学杂志,2018,47(11):14931495.
[7]任国明.复方丹参滴丸联合西药治疗冠心病心绞痛的临床疗效[J].中西医结合心血管病杂志,2016,4(27):170171.
[8]彭宾宾,韩颖,韩清华.麝香保心丸治疗稳定型心绞痛的疗效观察[J].中西医结合心脑血管病杂志,2017,15(4):460462.
[9]汪剑飞.太子参药理研究新进展[J].实用药物与临床,2013,16(4):333334.
[10]马丙详,董宠凯.丹参的药理作用研究新进展[J].中国药房,2014,25(7):663665.
[11]孙丽娜,王森林,唐可欣,等.胸痹通胶囊调节血脂代谢的分子机制研究[J].医学研究杂志,2010,39(9):6668.
[12]唐可欣,王金光.胸痹通胶囊对高脂血症大鼠脂质过氧化的影响[J].中国临床康复,2004,8(18):35523553.
[13]王凤斌.胸痹通胶囊影响兔动脉壁一氧化氮代谢的实验研究[J].中西医结合心脑血管病杂志,2010,2(2):9394.
[14]唐可清,田立.胸痹通胶囊对大鼠血液流变学的影响[J].中医药信息,2003,20(4):5253.
[15]夏毓,王金光,王凤斌,等.胸痹通胶囊对大鼠缺血心肌保护作用的研究[J].中医学结合心脑血管病杂志,2003,1(10):584585.

备注/Memo

备注/Memo:
山东省潍坊市卫生和计划生育委员会中医药科研项目（第20184020号）
更新日期/Last Update: 2019-11-15